Enfusion - Competitors and Alternatives

A Detailed Breakdown of the

Features of Enfusion

Are you considering Enfusion alternatives for your investment management needs? We start by listing functionality of Enfusion compared to Limina and then list additional competitors.

Note: Vendor information here is based on company websites, industry publications and online review sites such as G2, Gartner, TrustRadius and Capterra. Such pages have been reviewed in June 2024 as a basis for this article.

System capabilities

Enfusion

Limina IMS

Order Management

Simulate portfolio changes

Rebalancing & order entry workflows

Investment compliance

Order planner

Portfolio monitoring & performance

Real-time sensitivities

P&L

Compare vs benchmark

Look-through (funds, indices, derivatives)

Performance Attribution

Risk Management

Value-at-Risk (VaR)

Scenario analysis

Sensitivities

IBOR & Middle Office

Shadow NAV

Reconciliation

Reporting

Data quality controls

Import-export engine

A list of the

Best Enfusion Competitors

Enfusion’s front-to-back-office software covers a wide set of functionality, covering features from order raising to shadow NAV. It was initially built for hedge funds. As such, it covers a wide range of asset classes and was initially built for simple order raising workflows (e.g. single order and strategy trades). In recent years, workflows for model portfolios, benchmarks and rebalancing has been developed.

A natural strength of Enfusion is its end-to-end workflows across the full investment lifecycle. This is thanks to most functions being covered in the single system. The system’s core architecture is multi-tenant. The main disadvantage of this approach is that data isn't isolated between you and other investment managers (shared database).

Below are five alternatives to Enfusion you might want to consider:

Limina IMS

The team behind Limina are former hedge fund managers. We’ve not just faced the heat of the markets - but also the challenges of selecting the right investment management platform. Having been in your shoes, we've created this guide to help make your decision easier.

Limina is a web-based investment management platform that is often a powerful alternative to Enfusion. If you’d like to learn more about Limina, here are some resources that you might find helpful:

Bloomberg AIM

Bloomberg AIM (part of Bloomberg buy-side solutions and PMGO) is an order management system. It provides a suite of capabilities for rebalancing, pre-trade compliance, and post-trade processing.

AIM is embedded in the Bloomberg Terminal, which means it connects to market data readily available to terminal users. The flipside is that AIM doesn't as natively interplay with data sources or execution management systems from other vendors.

AIM integrates with other Bloomberg products (such as TCA & risk analytics), but such integrations are also possible for other providers (such as Enfusion). In other words, such connectivity isn't a proposition unique to AIM.

Broadridge Paladyne

Paladyne was acquired by Broadridge in 2011, just six years after its founding. It built and delivered a solution primarily to hedge funds, similar in scope to Enfusion.

Broadridge has since rebranded the offering at least once, and it's not apparent from online sources what product is available for new clients nowadays.

Charles River

Charles River Investment Management System (CRIMS) is a strong platform, especially for the Front Office. It has sophisticated order and execution management features. The execution management system connects to trade venues and liquidity providers for effective execution.

The platform is used by some of the largest asset managers in the world. Some online comments note long implementation times as a concern.

SS&C Eze

SS&C has many products that could compete with Enfusion (and themselves at times). The first is Eze OMS (Order Management System) and Tradar (Portfolio Accounting), two products initially created to service hedge funds. Eze OMS and Tradar have been integrated with realtick (Eze’s EMS) to create the Eze Investment Suite. This integrated solution

In 2018, SS&C acquired Eze Software from TPG for $1.45 billion. SS&C already owned Advent, which has solutions that partly overlap with Eze. Nowadays, there is also a solution called Aloha available from SS&C, and they have a web-based tool called Ecplise.

From online sources, it appears unclear which respective product is suited for which type of investment manager or use case.

Why consider Limina's Investment Management System

When looking at the capabilities of a platform, it’s important to remember that merely having the functionality isn’t enough. Here are the top three reasons why firms choose Limina as an alternative to Enfusion:

No workarounds With all features covered, there is no need for workflows outside the system.

Save 4 hours per day Efficient workflows and clever automation through an exception-based approach.

No data errors Data quality controls is always on, checking imports and data entry

What clients are saying

AvanzaAsset management department of bank

By adopting Limina's scalable platform, Avanza has launched 33% additional funds without having to scale its investment operations team. They achieved:

Decreased dependency on single individuals - by replacing spreadsheets
Improved operational efficiency - by increased automation

AtleBoutique asset manager

"It’s such a modern portfolio management system – not only because it’s cloud-based, but the entire process flow and information I get is complete and up to date. It’s simple to use, flexible to work with, and it minimises the time for the entire trade workflow." / Portfolio Manager
"Limina helps us reduce operational risks." / CEO

Enfusion - Competitors and Alternatives

Features of Enfusion

Best Enfusion Competitors

Limina IMS

Bloomberg AIM

Broadridge Paladyne

Charles River

SS&C Eze

Why consider Limina's Investment Management System

Switch from Enfusion

What clients are saying

See a modern system in action today